Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. XOMA
XOMA logo

XOMA Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Xoma Royalty Corp (XOMA) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
40.000
1 Day change
0.73%
52 Week Range
40.740
Analysis Updated At
2026/04/17
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Based on the data provided, Xoma Royalty Corp (XOMA) is not a strong buy for a beginner investor with a long-term focus. While the stock shows bullish technical indicators and a positive analyst rating, the lack of significant trading trends, weak financial performance in the latest quarter, and no recent news or catalysts suggest holding off on investment at this time.

Technical Analysis

The stock is showing bullish technical indicators with MACD above 0 and positively contracting, RSI at 86.746 indicating overbought conditions, and bullish moving averages (SMA_5 > SMA_20 > SMA_200). However, the stock is nearing resistance levels (R1: 39.794, R2: 41.821), which could limit upside potential in the short term.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
4
Buy
9

Positive Catalysts

  • Bullish technical indicators.

Neutral/Negative Catalysts

  • No significant trading trends from hedge funds or insiders. Financial performance shows a significant drop in net income (-162.29% YoY) and EPS (-157.78% YoY) despite revenue growth. No recent news or event-driven catalysts. Overbought RSI suggests potential short-term pullback.

Financial Performance

In 2025/Q4, revenue increased by 57.87% YoY to $13.76 million, but net income dropped significantly by -162.29% YoY to $3.32 million. EPS also declined by -157.78% YoY to 0.26. Gross margin remained stable at 100%.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Leerink raised the price target to $50 from $45 and maintained an Outperform rating, indicating positive sentiment from analysts.

Wall Street analysts forecast XOMA stock price to rise
5 Analyst Rating
Wall Street analysts forecast XOMA stock price to rise
4 Buy
1 Hold
0 Sell
Strong Buy
Current: 39.710
sliders
Low
50
Averages
71
High
97
Current: 39.710
sliders
Low
50
Averages
71
High
97
Leerink
Outperform
upgrade
$45 -> $50
AI Analysis
2026-02-24
Reason
Leerink
Price Target
$45 -> $50
AI Analysis
2026-02-24
upgrade
Outperform
Reason
Leerink raised the firm's price target on Xoma to $50 from $45 and keeps an Outperform rating on the shares.
Lucid Capital
NULL -> Buy
initiated
$76
2025-12-09
Reason
Lucid Capital
Price Target
$76
2025-12-09
initiated
NULL -> Buy
Reason
Lucid Capital initiated coverage of Xoma with a Buy rating and $76 price target. The company has assembled a royalty portfolio from six commercial and nine Phase 3- stage small molecule and biological assets, the analyst tells investors in a research note. The firm says Xoma expects to collect over $1B in milestones and royalties over the next 15 years. Lucid believes that by building a diversified portfolio, the company mitigates single-asset risk while retaining exposure to substantial long-term value creation.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for XOMA
Unlock Now

People Also Watch